At a glance
This program funds innovative research on tuberous sclerosis complex that could lead to new discoveries or better patient care, including mechanistic studies, animal models, biomarkers, therapeutics, and patient-centered studies. Eligible applicants include U.S. Department of War organizations and foreign or domestic, for-profit or nonprofit, public or private organizations; awards go to eligible organizations, not individuals. The program expects to fund about four awards at up to $800,000 in total costs each for up to 3 years. Cost sharing is not required, clinical trials are not allowed, and New-to-the-Field and Established Investigator applications compete separately.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Idea Development Award (IDA) supports conceptually innovative and high-impact research that could ultimately lead to critical discoveries in tuberous sclerosis complex (TSC) research and/or improvements in patient care. Distinctive Features: This funding mechanism allows for established and new-to-the-field investigators. New-to-the-field investigators are independent investigators that are early in their faculty appointments and/or established investigators transitioned from other research fields into TSC research. Applications to the New-to-the-Field option will compete separately from the Established Investigators submitting to the regular Idea Development Award (IDA).
Who can apply
- Unrestricted